Zhongzhi Pharmaceutical Holdings Limited (HKG:3737)

Market Cap	639.06M -25.3%
Revenue (ttm)	2.20B -1.8%
Net Income	22.52M -81.5%
EPS	0.02 -84.0%
Shares Out	863.60M
PE Ratio	32.38
Forward PE	n/a
Dividend	0.05 (6.76%)
Ex-Dividend Date	May 23, 2025

Volume	358,000
Average Volume	388,500
Open	0.7200
Previous Close	0.7400
Day's Range	0.7200 - 0.7400
52-Week Range	0.5000 - 1.0000
Beta	0.47
RSI	52.95
Earnings Date	Mar 25, 2026

About HKG:3737

Zhongzhi Pharmaceutical Holdings Limited, an investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products in the People’s Republic of China. The company operates through Pharmaceutical Manufacturing and Operation of Chain Pharmacies segments. It also provides Chinese patent medicines and decoction pieces under the Zeus, Liumian, and Caojinghua brand names. In addition, the company manufactures and sells food and Chinese herbs; offers detection and testing services; and manages properties. Fu...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1993
• Employees: 2,488
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 3737

Financial Performance

In 2024, HKG:3737's revenue was 2.21 billion, an increase of 8.05% compared to the previous year's 2.05 billion. Earnings were 95.21 million, a decrease of -41.51%.

Financial numbers in CNY